| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 190,311 | 187,181 | 196,475 | 391,380 | | Cost of Revenue | (49,248) | 129,497 | 137,096 | (7,035) | | | Gross Profit | 239,559 | 57,684 | 59,379 | 398,415 | | | Operating Expenses | | Research Development | 28,396 | 28,101 | 28,374 | 30,632 | | Selling General and Administrative | 205,421 | 26,581 | 30,138 | 306,582 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 15,655 | 15,279 | 15,401 | 18,650 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (9,913) | (12,277) | (14,534) | 42,551 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 131 | 448 | (78) | (2,019) | | Earnings Before Interest And Taxes | (9,782) | (11,829) | (14,612) | 40,532 | | Interest Expense | 4,897 | 4,759 | 4,796 | 2,708 | | Income Before Tax | (14,679) | (16,588) | (19,408) | 37,824 | | Income Tax Expense | (5,273) | (3,475) | (7,298) | 13,383 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (9,406) | (13,113) | (12,110) | 24,441 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (9,406) | (13,113) | (12,110) | 24,441 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($9,406) | ($13,113) | ($12,110) | $24,441 |
|
0.51% Nasdaq 
Income Statement
